Chinese General Practice ›› 2022, Vol. 25 ›› Issue (36): 4601-4608.DOI: 10.12114/j.issn.1007-9572.2022.0277
Special Issue: 家庭医学的方法学精华特刊
• Research Methodology • Previous Articles
Received:
2021-12-20
Revised:
2022-05-20
Published:
2022-12-20
Online:
2022-06-30
Contact:
LIU Jue
About author:
通讯作者:
刘珏
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0277
分组 | 检测阳性 | 检测阴性 |
---|---|---|
暴露 | a | b |
未暴露 | c | d |
Table 1 Fourfold table method for analyzing the test-negative design
分组 | 检测阳性 | 检测阴性 |
---|---|---|
暴露 | a | b |
未暴露 | c | d |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
张力,金鹏飞,李靖欣,等. 检测阴性设计在疫苗效果评价中的应用[J]. 中华流行病学杂志,2020,41(2):280-283. DOI:10.3760/cma.j.issn.0254-6450.2020.02.024.
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[51] |
|
[52] |
World Health Organization.The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline[EB/OL]. (2021-12-10)[2021-12-13].
|
[53] |
World Health Organization. 8 Vaccines Approved for Use by WHO[EB/OL]. (2021-12-10)[2021-12-13].
|
[54] |
|
[55] |
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[60] |
|
[61] |
|
[62] |
|
[63] |
|
[64] |
骆淑英,朱军礼,吕梅斋,等. 基于实验室检测结果病例-对照研究评价6~72月龄儿童流感疫苗效果[J]. 中华预防医学杂志,2019,53(6):576-580. DOI:10.3760/cma.j.issn.0253?9624.2019.06.007.
|
[65] |
杨孝坤. 我国流感疫苗保护效果评价[R]. 北京:中国疾病预防控制中心,2021.
|
[66] |
|
[67] |
|
[68] |
刘巧,刘珏,刘民. 无症状感染者对COVID-19流行的影响及其防控措施研究[J]. 中国全科医学,2021,24(8):917-922. DOI:10.12114/j.issn.1007-9572.2021.00.416.
|
[69] |
杜敏,刘民,刘珏. 新型冠状病毒Delta变异株的流行病学特征及防控研究进展[J]. 中华流行病学杂志,2021,42(10):1774-1779. DOI:10.3760/cma.j.cn112338-20210808-00619.
|
[70] |
吴俣,刘珏,刘民,等. 新型冠状病毒Omicron变异株的流行病学特征及防控研究[J]. 中国全科医学,2022,25(1):14-19. DOI:10.12114/j.issn.1007-9572.2021.00.348.
|
[1] | LIU Li, HU Ran, KANG Guodong, ZHANG Lei, WANG Zhiguo. Analysis on the Status of 13-Valent Pneumococcal Conjugate Vaccine in Children Born from 2017 to 2022 in Jiangsu Province [J]. Chinese General Practice, 2025, 28(15): 1903-1907. |
[2] | YANG Hui. Advocating Qualitative Studies in Territory of General Practice [J]. Chinese General Practice, 2025, 28(12): 1421-1426. |
[3] | ZOU Chuan, OU Jianming, ZENG Xin, PENG Tao, ZHOU Yan, XIAO Chunyao, TAO Hongxia, CHEN Qingqi, LIN Kai. Conducting Educational Intervention Research in General Practice: from Design to Publication [J]. Chinese General Practice, 2025, 28(04): 413-419. |
[4] | SUN Zhenyu, CHEN Jianping, SUN Wei, QIAN Dongfu, LAN Qing. How Does a Rigorous Case Study of Primary Healthcare Service Management Produced? [J]. Chinese General Practice, 2024, 27(31): 3870-3876. |
[5] | LI Songjiao, LEI Kangchen, HUANG Hongwen, SONG Jiali, CHANG Yinghui, FAN Xiaonong, LI Li, DU Yuzheng, LIU Jian, CAI Xinru, BIAN Lina, MENG Lina, SONG Qian, SHEN Yan, GE Wenyi, LIU Wei, LI Yibing, JIA Hongbo, GAO Ying, MA Congcong. Investigation on Risk Factors and Main Symptoms of Long COVID and Their Influences on the Follow-up Research [J]. Chinese General Practice, 2024, 27(26): 3240-3248. |
[6] | BAO Meiling, HUANG Cunrui, WANG Haoxiang. Advances in the Application of Discrete Choice Experiments in the Field of Human Resources for Health [J]. Chinese General Practice, 2024, 27(25): 3184-3191. |
[7] | YU Na, BAI Xiaoling, PANG Jin, NIU Yutian, HU Qing, WANG Yuanfang, YANG Rongze. The Experience of Inhaled COVID-19 Vaccination among First-line Medical Staff in Epidemic Prevention Aged≥18 Years in Guiyang City: a Qualitative Study [J]. Chinese General Practice, 2023, 26(36): 4575-4580. |
[8] | ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777. |
[9] | WU Jian, YU Chengcheng, YANG Yinmei, XIA Qingyun, LI Quanman, FU Xiaoli. COVID-19 Vaccination Behavior and Its Influencing Factors among the Elderly in Four Regions of China [J]. Chinese General Practice, 2023, 26(22): 2763-2770. |
[10] | CAO Xingyang, WANG Yang, XU Zhijie, XU Yanli. Primary Care and General Practice Research Paper Productivity Report in China in 2021 [J]. Chinese General Practice, 2022, 25(34): 4232-4240,4258. |
[11] | Yu WU, Jue LIU, Min LIU, Wannian LIANG. Research of Epidemiologic Feature and Control of SARS-CoV-2 Omicron Subvariants BA.4 and BA.5 [J]. Chinese General Practice, 2022, 25(30): 3721-3725. |
[12] | ZHOU Hong,Timothy Noel Stephens,LUO Yucheng,GUO Jingzhu,LIU Ye,CAI Xianli. Evaluation of the Effectiveness of a General Practice Clinical Skills Workshop Program [J]. Chinese General Practice, 2021, 24(34): 4372-4377. |
[13] | HUANG Yuyan,HUANG Houqiang,CHEN Peiyun,PENG Bo,CHEN Yingyi,ZHENG Silin. Summary of the Best Available Evidence for the Prevention and Control of Influenza Outbreaks in Nursing Homes [J]. Chinese General Practice, 2021, 24(15): 1867-1873. |
[14] | SHAO Meng,WU Fang,ZHANG Jie,DONG Jiangtao,LIU Xiaoling,WU Jiangdong,ZHANG Le,ZHAO Haijun,ZHANG Wanjiang. Effects of a New Tuberculosis Vaccine Strain on T Cell Immune Memory and Proliferation Capacity [J]. Chinese General Practice, 2021, 24(11): 1376-1382. |
[15] | PAN Zihan,PANG Hui,CHI Chunhua,WU Yangfeng,ZHENG Jiaqiang. Application of Qualitative Research Methods in General Practice Research in China [J]. Chinese General Practice, 2021, 24(10): 1277-1283. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||